Mental Health
News
Novel antidepressant shows promise
as add-on therapy
Adjunctive treatment with the novel oral medication REL-1017 (esmethadone) is effective in adults with major depressive disorder (MDD) who have...
Commentary
10 reasons why Omicron could cause big destruction
“The most effective way to encourage people to obtain a vaccination is to use communication free of judgment and criticism.”
News
Asthma treatment does not appear to raise risk of neuropsychiatric disease
The FDA has previously warned of the risk for neuropsychiatric drug reactions for leukotriene receptor antagonists – including a boxed warning for...
News
New data support a causal role for depression in Alzheimer’s
“If we can treat the depression early on, we may help reduce risk for dementia for our patients later in life,” said coinvestigator Dr. Aliza P....
News
Schizophrenia linked to violent behavior, but experts push back
“I think one of the main implications of this study is that prevention of violence outcomes really should be a focus for clinical services,” said...
News
Opioid agonist therapy guards against self-harm, suicide
These results highlight the importance of a ‘transition’ period when stopping OAT, said study investigator Dr. Prianka Padmanathan.
News
New understanding of suicide attempts emerges
The genetic underpinnings of suicide attempts are partially shared and partially distinct from those of related psychiatric disorders.
News
Fish oil: ‘No net benefit’ for depression prevention?
The VITAL-DEP study included more than 18,000 adult partipants who were free of clinically relevant depressive symptoms at baseline.
Commentary
COVID-19 and coping with superimposed traumas
Empathy burnout is also a real and important facet in the equation, said Dr. Cassondra Feldman.
News
FDA grants new indication to lumateperone (Caplyta) for bipolar depression
This makes lumateperone the only FDA-approved drug for adults with depressive episodes associated with bipolar I and II disorder.